75 related articles for article (PubMed ID: 2751266)
1. Involvement of effector cells in the treatment with endotoxins of peritoneal carcinomatosis induced by colon tumour cells.
Lagadec P; Jeannin JF; Pelletier H; Reisser D; Olsson NO
Anticancer Res; 1989; 9(2):421-5. PubMed ID: 2751266
[TBL] [Abstract][Full Text] [Related]
2. Treatment with endotoxins of peritoneal carcinomatosis induced by colon tumor cells in the rat.
Lagadec P; Jeannin JF; Reisser D; Pelletier H; Olsson O
Invasion Metastasis; 1987; 7(2):83-95. PubMed ID: 3583623
[TBL] [Abstract][Full Text] [Related]
3. Metastatic pattern of CC531 colon carcinoma cells in the abdominal cavity: an experimental model of peritoneal carcinomatosis in rats.
Lopes Cardozo AM; Gupta A; Koppe MJ; Meijer S; van Leeuwen PA; Beelen RJ; Bleichrodt RP
Eur J Surg Oncol; 2001 Jun; 27(4):359-63. PubMed ID: 11417980
[TBL] [Abstract][Full Text] [Related]
4. An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis.
Perrin P; Cassagnau E; Burg C; Patry Y; Vavasseur F; Harb J; Le Pendu J; Douillard JY; Galmiche JP; Bornet F
Gastroenterology; 1994 Dec; 107(6):1697-708. PubMed ID: 7958681
[TBL] [Abstract][Full Text] [Related]
5. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.
Koppe MJ; Hendriks T; Boerman OC; Oyen WJ; Bleichrodt RP
J Nucl Med; 2006 Nov; 47(11):1867-74. PubMed ID: 17079821
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of peritoneal dissemination of murine colon carcinoma cells by administrating retrovirus harboring IL-2 gene.
Gunji Y; Tasaki K; Tagawa M; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Sakiyama S
Cancer Gene Ther; 1998; 5(6):339-43. PubMed ID: 9917087
[TBL] [Abstract][Full Text] [Related]
9. Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cells.
Lechanteur C; Moutschen M; Princen F; Lopez M; Franzen E; Gielen J; Bours V; Merville MP
Cancer Gene Ther; 2000 May; 7(5):676-82. PubMed ID: 10830715
[TBL] [Abstract][Full Text] [Related]
10. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses.
Wildner O; Morris JC
J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429
[TBL] [Abstract][Full Text] [Related]
11. Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1beta mediated by a tumor-specific vector, HVJ cationic liposomes.
Miyata T; Yamamoto S; Sakamoto K; Morishita R; Kaneda Y
Cancer Gene Ther; 2001 Nov; 8(11):852-60. PubMed ID: 11773975
[TBL] [Abstract][Full Text] [Related]
12. Involvement of T lymphocytes in curative effect of a new immunomodulator OM 163 on rat colon cancer metastases.
Onier N; Lejeune P; Martin M; Hammann A; Bauer J; Hirt P; Lagadec P; Jeannin JF
Eur J Cancer; 1993; 29A(14):2003-9. PubMed ID: 8280496
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model.
Hribaschek A; Ridwelski K; Pross M; Meyer F; Kuhn R; Halangk W; Boltze C; Lippert H
Oncol Rep; 2003; 10(6):1793-8. PubMed ID: 14534698
[TBL] [Abstract][Full Text] [Related]
14. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative.
Ghiringhelli F; Larmonier N; Schmitt E; Parcellier A; Cathelin D; Garrido C; Chauffert B; Solary E; Bonnotte B; Martin F
Eur J Immunol; 2004 Feb; 34(2):336-44. PubMed ID: 14768038
[TBL] [Abstract][Full Text] [Related]
15. The post-surgical inflammatory response provokes enhanced tumour recurrence: a crucial role for neutrophils.
van den Tol MP; ten Raa S; van Grevenstein WM; van Rossen ME; Jeekel J; van Eijck CH
Dig Surg; 2007; 24(5):388-94. PubMed ID: 17785985
[TBL] [Abstract][Full Text] [Related]
16. Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2.
Bevanda M; Orsolic N; Basic I; Vukojevic K; Benkovic V; Horvat Knezevic A; Lisicic D; Dikic D; Kujundzic M
Int J Hyperthermia; 2009 Mar; 25(2):132-40. PubMed ID: 19337913
[TBL] [Abstract][Full Text] [Related]
17. Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice.
Favoulet P; Benoit L; Osmak L; Polycarpe E; Esquis P; Duvillard C; Guiu B; Rat P; Favre JP; Chauffert B
World J Surg; 2004 May; 28(5):451-6. PubMed ID: 15085402
[TBL] [Abstract][Full Text] [Related]
18. Regression induced by lentinan, of peritoneal carcinomatoses in a model of colon cancer in rat.
Jeannin JF; Lagadec P; Pelletier H; Reisser D; Olsson NO; Chihara G; Martin F
Int J Immunopharmacol; 1988; 10(7):855-61. PubMed ID: 3235240
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal involvement and free tumor cells in peritoneal cavity of patients with colon cancer.
Douard R; Cugnenc PH; Wind P; Bénichou J
Am J Clin Pathol; 2004 Jan; 121(1):154-5; author reply 155. PubMed ID: 14750253
[No Abstract] [Full Text] [Related]
20. Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors.
Hájková R; Indrová M; Jandlová T; Bubeník J; Reinis M
Folia Biol (Praha); 1999; 45(6):227-31. PubMed ID: 10732718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
